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Background & aim: Prunes (dried plums) are perceived to maintain healthy bowel function, however
their effects on gastrointestinal (GI) function are poorly researched and potential mechanisms of action
are not clear. We aimed to investigate the effect of prunes on stool output, whole gut transit time
(WGTT), gut microbiota and short-chain fatty acids (SCFA) in healthy adults
Methods: We conducted a parallel group, randomised controlled trial with three treatment arms in 120
healthy adults with low ﬁbre intakes and stool frequency of 3e6 stools/wk. Subjects were randomised to
80 g/d prunes (plus 300 ml/d water); 120 g/d prunes (plus 300 ml/d water) or control (300 ml/d water)
for 4 weeks. Stool weight was the primary outcome and determined by 7-day stool collection. Secondary
outcomes included stool frequency and consistency (stool diary), WGTT (radio-opaque markers), GI
symptoms (diary), microbiota (quantitative PCR) and SCFA (gas liquid chromatography). Group assign-
ment was concealed from the outcome assessors.
Results: There were signiﬁcantly greater increases in stool weight in both the 80 g/d (mean þ 22.2 g/d,
95% CI 1e45.3) and 120 g/d (þ32.8 g/d, 95% CI 13.9e51.7) prune groups compared with control (0.8 g/
d, 95% CI 17.2 to 15.6, P ¼ 0.026). Stool frequency was signiﬁcantly greater following 80 g/d (mean 6.8
bowel movements/wk, SD 3.8) and 120 g/d (5.6, SD 1.9) prune consumption compared with control (5.4,
SD 2.1) (P ¼ 0.023), but WGTT was unchanged. The incidence of ﬂatulence was signiﬁcantly higher after
prune consumption. There were no signiﬁcant differences in any of the bacteria measured, except for a
greater increase in Biﬁdobacteria across the groups (P ¼ 0.046). Prunes had no effect on SCFA or stool pH.
Conclusions: In healthy individuals with infrequent stool habits and low ﬁbre intake, prunes signiﬁcantly
increased stool weight and frequency and were well tolerated. Prunes may have health beneﬁts in
populations with low stool weight.
Clinical trial registry number and website: ISRCTN42793297 http://www.isrctn.com/ISRCTN42793297.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diseases and functional disorders of the gastrointestinal (GI)
tract, such as colorectal cancer, diverticular disease, haemorrhoidsNOVA, analysis of variance;
ody mass index; BMs, bowel
dence interval; GI, gastroin-
ccharides; qPCR, quantitative
d trial; SCFA, short chain fatty
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Ltd. This is an open access article uand constipation, are associated with a signiﬁcant healthcare
burden in developed countries [1]. Low stool weight and delayed
gastrointestinal transit time are considered important risk factors
[2]. Stool weight is relatively low in developed countries and
recommendations have been made to address this through
increasing ﬁbre intake [3]. There is substantial epidemiological
evidence that high dietary ﬁbre intake is related to lower risk of
developing these GI disorders [4]. The effects of ﬁbre on gut
function vary according to ﬁbre type and source [4]. Proposed
mechanisms for the beneﬁcial effects of ﬁbre include its impact on
increasing stool weight, reducing GI transit time and short-chain
fatty acid (SCFA) production [5].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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world, including 22.4e28 g/d for females and 28e33.6 g/d for
males in the United States [6] and 30 g/d in the United Kingdom [7],
with ranges of 25e35 g/d typically recommended [8]. However,
actual intakes of ﬁbre fall well below current recommendations in
many developed countries [9,10] and increasing the consumption
of foods naturally high in dietary ﬁbre represents a major
challenge.
Prunes (dried plums) are generally perceived to have a laxative
effect [11]. They are high in ﬁbre (~6 g/100 g), including hemicel-
lulose (3.0 g/100 g), pectin (2.1 g/100 g) and cellulose (0.9 g/100 g)
[12]. Some ﬁbres resist colonic fermentation (poorly fermented ﬁ-
bres) and increase stool water and volume due to mechanical
stimulation of GI peristalsis (e.g. cellulose) [13]. Other ﬁbres are
rapidly fermented by colonic microbiota (fermentable ﬁbres),
resulting in bacterial proliferation and production of SCFA (e.g.
pectin) [8]. Prunes contain other components that may inﬂuence
colonic health including sorbitol and phenolic chlorogenic acids,
both of which are not well absorbed by the small intestine [14,15]
and subsequently fermented by the microbiota [15,16]. In vitro
studies suggest they have prebiotic effects [17,18], whilst sorbitol
has a laxative effect [19] by increasing intestinal water volume [20].
Prunes are therefore a promising intervention for increasing ﬁbre
intake and impacting GI function.
A systematic review of randomised controlled trials (RCTs)
examining the effect of prunes on GI function found only four trials
and reported inconsistent results [21]. In one trial, 100 g/d prunes
were more effective than psyllium (Plantago ovata) for improving
stool frequency and consistency in constipation. The remaining
trials were conducted in healthy subjects, with GI function
measured as a secondary outcome, however, one trial reported that
100 g/d prunes increased stool weight [22], another reported
softening of stool consistency [23] and none reported effects on
stool frequency or GI symptoms. The included trials were small, of
limited quality and used self-reported, subjective measurements of
GI function. Therefore, we carried out a RCT examining the effect of
prunes, including any dose-dependent effects, on objective
markers of GI function. We hypothesised that consumption of 80 g/
d or 120 g/d of prunes in addition to normal diet would affect stool
weight in healthy adults with infrequent bowel movements and a
low ﬁbre intake.
2. Materials and methods
2.1. Subjects and recruitment
Subjects were recruited from London, United Kingdom, via
emails to students and staff within London universities, advertising
on websites, local newspaper and posters, and online clinical trial
databases. Inclusion criteria were subjects aged between 18 and 65
years with a stool frequency of 3e6 bowel movements per week.
Exclusion criteria were: functional constipation or irritable bowel
syndrome determined by Rome III criteria; habitual high ﬁbre
intake (>1  80 g/d whole grain cereal and >3  80 g/d fruit and
vegetables; or >5  80 g/d fruit and vegetables; or >3  80 g/
d whole grain cereal; or >2  30 g/month dried fruit); prune
dislike/allergy/intolerance; use of prebiotic, probiotic, antibiotic or
medication known to affect gut motility for four weeks before or
during the study; use of laxatives or ﬁbre supplements (>6  in
previous 3 months); GI or other major disease or surgery that may
affect gut motility (e.g. cardiovascular, endocrine, renal); eating
disorders; pregnant or lactating women; and abdominal exposure
to ionising radiation in last 12 months. Potential volunteers were
screened via telephone and completed a 7-day stool frequency
diary in order to assess eligibility.2.2. Study design and protocol
This was a 9 week, single center, 3-arm, parallel-group, rando-
mised controlled trial. Eligible subjects were provided with verbal
and written study information and gave their informed consent.
After a one week baseline period, subjects were randomly allocated
to one of three groups: control (no prunes plus 300 ml/d water);
80 g/d prunes (plus 300 ml/d water); 120 g/d prunes (plus 300 ml/
d water). Previous studies have reported an impact on stool weight
and/or frequency at a dose of 100 g of prunes per day [21], and
portions either side of this were selected in order to determine a
doseeresponse relationship, should one exist.
Prunes were of Californian origin and provided by the California
Dried Plum Board (US) in 80 g and 120 g sealed bags (pitted, edible
portion). Water was not provided but subjects were given plastic
beakers with instructions on measuring the correct volume of
water. Subjects were instructed to consume the intervention in
addition to their normal diet every day for 4 weeks and to cease
consumption after the intervention period. During the ﬁrst week of
the intervention, subjects were instructed to consume only half of
their allocated prunes and/or water in order to slowly increase
tolerance to ﬁbre and to consume the prunes and water together as
a snack, in divided doses, half in the morning (before 12:00) and
half in the afternoon/evening (after 15:00). Subjects were reques-
ted to maintain their regular lifestyle, diet, and physical activity
throughout the study but to refrain from using excluded dietary
supplements.
The primary outcome was stool weight. Secondary outcomes
were stool frequency, stool consistency, GI symptoms, GI transit
time, faecal microbiota, faecal SCFA concentrations and faecal pH.
Data on diet (7-d food diary), compliance and acceptability of the
intervention, and confounding variables including physical activity
(Recent Physical Activity Questionnaire, RPAQ) were also collected.
All outcomes were measured at baseline and week 4 of the inter-
vention. Stool frequency, consistency and GI symptoms were also
measured at week 2 of the intervention. Compliance was measured
during the ﬁnal 3 weeks of the intervention when subjects were
advised to consume the full dose of prunes.
Double blinding was not achievable because it was not possible
to develop a placebo identical to prunes but without any active
components. However, blinding of subjects was attempted by using
water in all groups (including the control group) and advertising
the study as an investigation of ‘ﬁbre or ﬂuids’ on GI health,
therefore subjects in the water group were unaware they were in
the control group. Blinding of data and laboratory samples was
achieved by the recoding of subject identiﬁcation and group allo-
cation by an independent researcher.
Randomisation was by permuted block design, stratiﬁed by
gender. Sequence generation was undertaken by a researcher un-
involved with the current study using an online random number
generator with a 1:1:1 allocation using ﬁxed block sizes of 18. The
allocation sequence was concealed from the researchers in
sequentially numbered, opaque, sealed envelopes.2.3. Outcome measures
2.3.1. Stool output and GI symptoms
The primary outcome of stool weight was calculated from total
stool collections made on 7 consecutive days. Subjects were pro-
vided with verbal and written instructions on how to collect stools
and provided with a stool collection kit and plastic storage boxes.
Brieﬂy, subjects passed a stool onto the stool collection device and
then stored it in a sealed plastic bag inside an air tight pouch. Stools
were labelled and returned to King's College London at a
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on a laboratory balance accurate to 0.1 g.
Stool frequency, consistency and GI symptoms were recorded in
a 7-day diary. Subjects contemporaneously recorded each bowel
movement and its consistency using the Bristol Stool Form Scale
(BSFS) [24]. The number of bowel movements (BMs) was recorded
over 7 days. The dates and times of the BMs recorded in the diary
were checked against 7-day stool collection data and any discrep-
ancies resolved with the subject during study visits. Stool consis-
tency was reported as the mean BSFS score of all stools over the 7
days and as the percentage of type 3 or type 4 over the 7 days.
At the end of each diary day, subjects completed the Gastroin-
testinal Symptom Rating Scale [25], recording the presence and
severity of 14 common GI symptoms (heartburn, acid reﬂux,
nausea, belching, borborygmus, bloating, pain/discomfort, ﬂatu-
lence, hard stools, constipation, diarrhoea, loose stools, urgency,
incomplete evacuation) on a Likert scale as absent (score 0), mild
(score 1), moderate (score 2) or severe (score 3). The incidence of
each symptom (mild, moderate or severe) and the incidence of
moderate and severe symptoms over the 7 days were reported.
2.3.2. Whole gut transit time
Radio-opaque markers followed by abdominal ﬂuoroscopy were
used to measure whole gut transit time (WGTT), using the Metcalf
method [26] at Queen Mary University of London. Subjects were
provided with 6 gelatin capsules, each containing 10 polyurethane
ring markers consisting of 40% barium sulphate (P & A Mauch,
Switzerland). Subjects were provided with verbal and written in-
structions to ingest 2 capsules at a predetermined time each day for
the ﬁrst three days of the 7-d stool collection/diary period. On the
fourth day an abdominal ﬂuoroscopy was taken at the same pre-
determined time. If subjects retained 30 radio-opaque markers, a
second X-ray was taken on the seventh day. WGTT was calculated
using the formula: TT ¼ ni  (t/N), where ni ¼ number of markers
observed at ﬂuoroscopy (ﬁrst and second ﬂuoroscopy combined);
t ¼ time between each marker ingestion in hours; and N ¼ number
of markers ingested each day.
2.3.3. Compliance and acceptability
Compliance was measured using both self-report and return of
unused prunes. Firstly, a diary was used in which subjects pro-
spectively recorded the time and the quantity of prunes and/or
water consumed each day. Secondly, subjects were provided with a
known number of bags of prunes, each of a knownweight andwere
asked to return all uneaten bags, which were checked against the
diary entries. Compliance was deﬁned as the number of subjects
who consumed at least 80% of their prunes or water during the ﬁnal
3-weeks of the intervention period.
Subjects in the intervention groups were asked to rate “How
much do you like the prunes” and “How difﬁcult was it to eat the
prunes” on a 100 mm visual analogue scale on the ﬁrst (d1) and
ﬁnal (d28) day of the intervention. The controls were asked
equivalent questions about water.
2.4. Laboratory methods
During each 7-day stool collection period, one fresh stool sam-
ple was collected from subjects within 1 h of evacuation. The stool
was immediately homogenised in a stomacher (Steward laboratory
blender stomacher 400) for 4 min and aliquots taken for the
analysis of microbiota, SCFA, pH and water content.
2.4.1. Gut microbiota
Gut microbiota were analysed using quantitative polymerase
chain reaction (qPCR). Fresh stool was diluted 1:3 with sterilephosphate buffered saline/30% glycerol buffer, homogenised and
frozen at 80 C until analysis. DNA was extracted from defrosted
stool using the FastDNA Spin for soil kit and the FastPrep-24 bead
homogeniser (MP Biomedicals, Solon, Ohio, USA) following man-
ufacturer's instructions (Qbiogene, MP Biomedicals, Illkirch,
France).
DNAwas diluted to 2$5 ng/ml in 5mg/ml herring spermDNA and
ampliﬁed with primers (Online supplemental material, Table S1).
Primers were selected to measure total bacteria, dominant phyla
and genera and those previously shown to be responsive to dietary
change. Ampliﬁed bacterial 16S rRNA genes served as standard
templates and standard curves were prepared with ﬁve standard
concentrations of 106 to 102 gene copies/ml in 5 g/ml herring sperm
DNA. A qPCR analysis of faecal DNA was performed in triplicate
using iTaq Universal SYBR Green Supermix (Biorad) in a total vol-
ume of 10 ml that comprised 5 ml SYBR green, 2 ml H20, 0.2 ml for-
ward primer, 0.2 ml reverse primer and 2 ml DNA standard template
or control (5 mg/ml herring sperm DNA and H20) in 384-well PCR
plates sealed with an optical adhesive cover. Ampliﬁcation was
performed with the 900HT fast real time PCR system (Life Tech-
nologies) with the following protocol: one cycle of 95 C for 3 min,
40 cycles of 95 C and the annealing temperature for each primer
(online supplemental material, Table S1) for 30 s each, one cycle of
95 C for 10 s, and a stepwise increase from 65 to 95 C (at 5 s per
0.5 C) to obtain melt curve data. Data were analysed using SDS
version 2.4.1 ABI 7900HT Applied Biosystems sequence detection
system (Life Technologies). Absolute quantiﬁcationwas determined
by comparison of the Cq values of the target template against the
standard curve.
Bacterial concentrations were corrected for stool water content
and were expressed as log10/dry faeces using data for stool water
content measured using lyophilisation. Brieﬂy, weighed and frozen
(20 C) stool samples were lyophilised at 45 C at a vacuum of
approximately 4 mBar for 4 days (LyolabA; LSL Secfroid SA, Aclens-
Lausanne, Switzerland), then weighed daily until constant weight
(within 0.01 g). Bacterial concentrations were expressed as log10/
dry faeces using lyophilisation data.
2.4.2. Short-chain fatty acids and pH
Homogenised fresh stools were frozen at 80 C until analysis.
SCFA were extracted from defrosted stool as previously described
using extraction buffer containing an internal standard 2, 2-dime-
thylbutyric acid [27]. Extracted SCFA (0.2 ml) were separated on a
7890A Aligent Technology gaseliquid chromatography system
equipped with a 220 mm internal diameter, 25 m fused silica
capillary column with a ﬁlm thickness of 0.25 mm (ID-BP21, SGE,
Australia). The initial oven temperature was 80 C, increasing to
145 C at 10 C/min and then increasing to 200 C at 100 C/min. All
chromatograms were automatically integrated using the Agilent
Chromatogram database (Agilent Technologies, US).
For stool pH analysis, fresh stool was diluted 1:4 (vol:vol) in pH
buffer (1  105 mol/L Na2HPO4, KH2PO4, 0.1 g HgCl2), homoge-
nised for 4 min and incubated at room temperature for 1 h. pH was
measured using a calibrated pH meter (Hanna Instruments,
Portable pH meter), equipped with a glass electrode speciﬁcally
designed for slurries (Beckman Coulter pHRESH Electrode).
2.5. Ethics
Ethical approval was granted from the West London NHS
Research Ethics Committee and the research was conducted ac-
cording to the Declaration of Helsinki. All subjects gave their
written informed consent. There were no important protocol
changes once the trial commenced. The trial was registered in
advance of trial commencement (ISRCTN42793297).
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To detect a difference in the primary outcome of stool weight
between the three groups with a power of 0.95 and a 0.01 level of
signiﬁcance, a total sample size of 108 (36 subjects in each group)
was required. This was based on variance estimates of change in
stool weight of mean 6.0 g/d (range 1.4e19.6) per 1 g of fruit and
vegetable ﬁbre [28]. We estimated the standard deviation (3.0)
from the range using the range formula (range/6) for large samples.
We aimed to recruit 120 subjects (40 in each group) to allow for an
estimated 10% attrition.
The primary analysis was based on the intention to treat (ITT)
data set, including all randomised subjects in the group to which
theywere allocated regardless of protocol deviations or attrition and
last observation carried forward was used to account for missing
data. A per protocol analysis was also conducted on the primary
outcome only, which included only subjects who completed the
intervention and who were compliant with the study protocol.
Data were checked for normality and outliers using histograms
and box plots and logarithmic transformation was applied to non-
normally distributed data. Differences between the groups were
assessed using analysis of covariance (ANCOVA) with baseline valueFig. 1. Consort diagram. ITT ¼ intention to treat; PP ¼ per protocas a covariate or the KruskaleWallis test if transformation did not
result in sufﬁciently normal distribution. Changes from baseline
were tested using one way analysis of variance (ANOVA) or the
KruskaleWallis test if transformation did not result in sufﬁciently
normal distribution. Categorical variables were assessed using the
chi-squared test. Planned orthogonal comparisons (both prune
interventions combined vs control and 120 g/d prunes vs 80 g/
d prunes) were used instead of post hoc tests since they provide
direct tests of the hypotheses of interest, control the type 1 error
and are more statistically powerful than post hoc testing [29].
Results are presented as means and SD or median and inter-
quartile range (IQR), as appropriate. All tests were two-tailed and P
values < 0.05 were considered statistically signiﬁcant. Data were
analysed using IBM SPSS Statistics for Windows, version 22.
3. Results
3.1. Subject characteristics
In total, 343 subjects were screened for eligibility between
January 2012 and September 2013, of whom 120 were randomised
(40 in each group) and included in the ITT analysis (Fig. 1). Of these,ol.*subjects may appear in more than one exclusion category.
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included in the per protocol analysis of the primary outcome.
Baseline characteristics are shown in Table 1.
3.2. Compliance, acceptability and nutrient intake
During the ﬁnal 3 weeks of intervention, 90% of subjects in the
80 g/d prune group, 88% in the 120 g/d prune group and 97% in the
control group reported compliance with the prune or water regi-
mens respectively. In both prune groups, there was a signiﬁcant
decrease in liking of the prunes and subjects found it signiﬁcantly
more difﬁcult to eat the prunes on day 28 than day 1 of the inter-
vention (data not shown). However, there were no signiﬁcant
changes in self-reported compliance between weeks 2 and 4
(P ¼ 0.427).Table 1
Baseline characteristics of subjects by intervention group.
Control
(n ¼ 40)
80 g/d prunes
(n ¼ 40)
120 g/d prunes
(n ¼ 40)
Age (y) 36.5 (13.5) 33.5 (13.1) 34.4 (11.8)
Females, n (%) 28 (70) 29 (73) 29 (73)
Post-menopausal, n (%) 6 (15) 3 (8) 1 (3)
BMI (kg/m2) 25.4 (4.9) 23.9 (4.5) 25.2 (4.5)
Physical activity
energy expenditure
(kJ/kg/d) (RPAQ)
35.2 (18.7) 40.7 (25.7) 34.0 (21.2)
Stool weight (g/d) 110.9 (46.1) 87.9 (44.2) 89.9 (51.6)
Stool frequency (per week) 5.4 (1.4) 5.1 (2.1) 4.9 (2.0)
Stool consistency
(Bristol stool form scale)
4.0 (1.1) 3.5 (1.0) 3.2 (1.2)
Whole gut transit time (h) 40.7 (27.7) 41.8 (28.4) 46.8 (28.2)
Values are mean (SD) unless otherwise stated.
BMI body mass index.
Table 3
Stool output and consistency and transit time at baseline (week 0) and end of the interv
Valuesa Control (n ¼ 40) 80 g/d prunes (n ¼ 40) 12
Baseline Intervention Baseline Intervention B
Stool weight (g/d) 111 (46) 110 (62) 87.9 (44.2) 111 (69) 89
Stool weight (g/d)
(per protocol, n ¼ 91)
110 (44) 112 (63) 87.4 (37.8) 115 (72) 99
Stool frequency (BM/wk) 5.4 (1.4) 5.4 (2.1) 5.1 (2.1) 6.8 (3.8) 4.
Stool consistency (BSFS) 4.0 (1.4) 4.1 (1.7) 3.5 (1.3) 3.8 (1.9) 3.
Percentage type 3/4 stools 46.5 (65.1) 50.0 (45.9) 59.2 (49.1) 45.0 (77.7) 50
Whole gut transit time (h) 40.7 (27.3) 35.3 (28.5) 41.8 (28.4) 33.9 (27.1) 46
ITT: intention to treat; PP: per protocol.
a Values are mean (SD), except for stool consistency score where values are median (I
weight which is given as both ITT (n ¼ 120) and per protocol (n ¼ 91).
b P values are the result of an Analysis of Covariance (ANCOVA) for the intervention da
result of a KruskaleWallis test.
c P values are the result of planned contrasts.
Table 2
Total energy, macronutrient, ﬁbre intakes and body weight at baseline and week 4 (end
Valuesa Control (n ¼ 40) 80 g/d prunes (n ¼ 40)
Baseline Intervention Baseline Intervention
Energy (kcal/d) 1868 (469) 1570 (345) 1869 (597) 1880 (623)
Protein (g/d) 68.9 (18.2) 62.0 (17.0) 68.3 (21.8) 70.4 (23.7)
Fat (g/d) 78.0 (23.2) 63.2 (18.5) 78.2 (26.0) 73.5 (28.6)
Carbohydrate (g/d) 224 (61) 188 (50) 223 (91) 232 (81)
AOAC ﬁbre (g/d) 15.3 (4.8) 13.5 (4.5) 15.3 (6.9) 19.8 (7.7)
Non-starch polysaccharide (g/d) 10.8 (3.6) 9.6 (3.2) 10.4 (4.6) 14.0 (28.9)
Body weight (kg) 71.1 (13.7) 71.1 (13.9) 68.1 (12.7) 68.5 (12.8)
a Values are mean (SD).
b P values are the result of an Analysis of Covariance (ANCOVA) for the intervention d
c P values are the result of planned contrasts.During week 4, intakes of energy, carbohydrate, protein, fat and
ﬁbre were signiﬁcantly higher in the prune intervention groups
(80 g/d and 120 g/d groups combined) than control (Table 2). Intake
of carbohydrate was higher in the 120 g/d prune group than the
80 g/d prune group. Despite the higher energy intake in the prune
groups, there were no signiﬁcant differences in body weight be-
tween the groups at week 4 (Table 2). There were no signiﬁcant
differences in physical activity energy expenditure between the
controls (mean 35.0 kJ/kg/d, SD 24.5), 80 g/d (42.8 kJ/kg/d, 30.4) or
120 g/d (35.8 kJ/kg/d, 22.5) groups at week 4.
3.3. Stool output and whole gut transit time
In the ITT analysis, stool weight was not signiﬁcantly different
between the groups at week 4 (P¼ 0.072) (Table 3). However, in the
per protocol analysis (only subjects who completed, and were
compliant with, the intervention), stool weight was signiﬁcantly
different between the groups (P ¼ 0.039), and in the planned
contrasts was signiﬁcantly higher following prune consumption
comparedwith control, but not between 80 g/d and 120 g/d prunes.
In both the ITT and per protocol analyses, there was a signiﬁcantly
greater change in stool weight from baseline toweek 4 between the
groups (P ¼ 0.026), and in the planned contrasts this was signiﬁ-
cantly higher for subjects consuming prunes compared with con-
trols, but not different between 80 g/d and 120 g/d prunes (Fig. 2).
Stool frequency was signiﬁcantly different between the groups
(P ¼ 0.023), and in the planned contrasts, the prune groups re-
ported signiﬁcantly more frequent bowel movements than con-
trols, but there were no signiﬁcant differences between 80 g/d and
120 g/d prunes (Table 3). In terms of stool consistency, there were
no signiﬁcant differences between groups in BSFS score at week 4
of the intervention, and no signiﬁcant differences in the percentageention (week 4).
0 g/d prunes (n ¼ 40) P valuesb
aseline Intervention Interventionb Prunes vs controlc 80 g/d vs. 120 g/dc
.9 (50.7) 123 (71) 0.072 e e
.2 (56.1) 140 (74) 0.039 0.035 0.132
9 (2.0) 5.6 (1.9) 0.023 0.031 0.089
2 (1.6) 3.0 (3.0) 0.259 e e
.0 (71.9) 61.3 (65.1) 0.372 e e
.6 (27.5) 41.0 (26.7) 0.507 e e
QR). All analyses are on the intention to treat population (n ¼ 120), except for stool
ta using baseline data as a covariate, except for stool consistency score which is the
of intervention).
120 g/d prunes (n ¼ 40) P values
Baseline Intervention Interventionb Prunes vs. Controlc 80 g/d vs. 120 g/dc
1873 (532) 1950 (628) <0.001 <0.001 0.390
70.4 (23.4) 66.3 (22.6) 0.041 0.046 0.116
79.0 (28.9) 74.2 (33.6) 0.034 0.009 0.959
214 (59) 251 (71) <0.001 <0.001 0.021
14.5 (4.6) 20.9 (6.8) <0.001 <0.001 0.109
10.1 (3.4) 15.2 (5.0) <0.001 <0.001 0.079
71.0 (13.7) 71.1 (13.5) 0.229 e e
ata using baseline data as a covariate.
Fig. 2. Change from baseline in stool weight (g/d) during consumption of prunes under the intention to treat and per protocol analyses. Data are presented as mean and
distribution bars are 95% conﬁdence intervals. ITT Analysis of variance, ITT Analysis of variance: F(2,117) [3.75], P ¼ 0.026; planned contrasts, prunes vs control (P ¼ 0.014) and 80 g/
d vs 120 g/d (P ¼ 0.259). PP Analysis of variance: F(2,88) [3.35], P ¼ 0.040; planned contrasts, prunes vs control (P ¼ 0.016) and 80 g/d vs 120 g/d (P ¼ 0.367).
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differences in WGTT between the groups (Table 3).
3.4. Gastrointestinal symptoms
There were no signiﬁcant differences between the groups at
week 4 for any of the symptoms recorded, except for acid reﬂux
(overall incidence) and ﬂatulence (overall incidence and incidence
of moderate or severe symptoms) (Table 4). Following the planned
contrasts for these symptoms, there were signiﬁcantly higher
values in subjects consuming prunes than those in the controlTable 4
Incidence and severity of gastrointestinal symptoms at week 4.
Incidence (d/wk)a
Control
(n ¼ 40)
80 g/d prunes
(n ¼ 40)
120 g/d prunes
(n ¼ 40)
Heartburn 0.2 (0.7) 0.2 (0.5) 0.5 (1.5)
Acid reﬂux 0.1 (0.2) 0.3 (0.8) 0.6 (1.3)
Nausea 0.4 (0.8) 0.5 (1.5) 0.7 (1.1)
Belching 1.8 (2.8) 1.8 (2.5) 1.8 (2.2)
Borborygmi 1.7 (2.5) 2.0 (2.3) 2.4 (2.5)
Abdominal bloating 1.8 (2.5) 2.2 (2.6) 2.3 (2.6)
Abdominal pain/discomfort 0.7 (1.3) 1.5 (2.2) 1.6 (2.2)
Flatulence 3.0 (2.8) 4.7 (2.7) 4.4 (2.6)
Hard stools 0.5 (1.2) 0.4 (0.8) 0.4 (0.8)
Constipation 0.5 (1.2) 0.6 (1.5) 0.8 (1.5)
Diarrhoea 0.2 (0.5) 0.5 (1.4) 0.2 (0.7)
Loose stools 0.7 (1.3) 1.0 (1.9) 0.5 (1.2)
Urgency 1.0 (1.3) 1.0 (1.6) 1.1 (1.5)
Incomplete evacuation 0.6 (1.4) 1.1 (1.9) 1.0 (1.9)
*Planned contrasts: Incidence acid reﬂux Prunes vs control (P ¼ 0.026) and 80 g/d vs 120
120 g/d (P ¼ 0.469); Incidence of moderate and severe ﬂatulence Prunes vs control (P ¼
a Values are mean (SD) days/week of GI symptoms measured during the ﬁnal week o
normally distributed, because most median values were zero and hence uninformative.
b P values are the result of a KruskaleWallis test.group, but no signiﬁcant differences between 80 g/d and 120 g/
d prunes.
3.4. Faecal microbiota, SCFA and pH
There were no signiﬁcant differences between groups at the
end of the intervention for any of the bacterial groups measured
(Table 5). However there was a signiﬁcant difference in the change
in Biﬁdobacteria from baseline between the control (median
change 0.0, IQR 0.8), 80 g/d (0.0, 1.1) and 120 g/d (þ0.3, 0.6)
(P ¼ 0.046, KruskaleWallis test), although neither of the plannedIncidence of moderate and severe symptoms (d/wk)a
P valueb Control
(n ¼ 40)
80 g/d prunes
(n ¼ 40)
120 g/d prunes
(n ¼ 40)
P valueb
0.731 0.1 (0.2) 0.1 (0.2) 0.0 (0.2) 0.813
0.038* 0.0 (0.0) 0.0 (0.2) 0.1 (0.3) 0.068
0.088 0.1 (0.3) 0.1 (0.5) 0.1 (0.3) 0.907
0.714 0.2 (0.5) 0.3 (1.2) 0.2 (0.7) 0.937
0.267 0.2 (0.4) 0.4 (1.4) 0.5 (1.4) 0.459
0.575 0.3 (0.7) 0.6 (1.6) 0.6 (1.4) 0.899
0.303 0.2 (0.4) 0.4 (1.1) 0.6 (1.2) 0.203
0.015* 0.4 (1.2) 1.4 (1.9) 1.7 (2.3) 0.005*
0.958 0.0 (0.2) 0.1 (0.8) 0.1 (0.3) 0.220
0.603 0.2 (0.8) 0.3 (1.0) 0.2 (0.6) 0.303
0.775 0.1 (0.3) 0.3 (1.1) 0.1 (0.3) 0.898
0.213 0.2 (0.5) 0.3 (1.1) 0.2 (0.5) 0.826
0.952 0.3 (0.6) 0.3 (0.6) 0.6 (0.8) 0.625
0.515 0.2 (0.8) 0.3 (1.0) 0.2 (0.5) 0.804
g/d (P ¼ 0.273); Incidence of ﬂatulence Prunes vs control (P ¼ 0.005) and 80 g/d vs
0.001) and 80 g/d vs 120 g/d (P ¼ 0.721).
f the intervention (week 4). Mean values are shown in spite of the data not being
Table 5
Concentrations of bacteria (log10/g dry faeces) at baseline (week 0) and end of the intervention (week 4).
Bacterial groupsa Control (n ¼ 39) 80 g/d prunes (n ¼ 40) 120 g/d prunes (n ¼ 38) P valueb
(intervention)
P valueb
(change from baseline)
Baseline Intervention Baseline Intervention Baseline Intervention
All bacteria 10.7 (0.4) 10.8 (0.6) 10.5 (0.6) 10.8 (0.7) 10.7 (0.3) 10.8 (0.5) 0.854 0.770
Biﬁdobacteria 9.1 (0.5) 9.1 (0.6) 8.8 (0.9) 9.3 (0.9) 8.9 (0.8) 9.0 (0.6) 0.554 0.046*
B. longum 8.9 (0.6) 8.8 (1.2) 8.7 (1.2) 8.9 (1.3) 8.4 (0.9) 9.1 (0.8) 0.264 0.096
B. adolescentis 8.3 (3.9) 8.4 (3.9) 8.1 (2.1) 8.1 (92.3) 7.9 (3.7) 8.4 (2.9) 0.907 0.619
Bacteroidetes 9.9 (0.4) 10.0 (0.8) 9.8 (0.6) 10.1 (0.8) 9.9 (0.4) 10.0 (0.6) 0.881 0.972
Bacteroides spp. 9.7 (0.5) 9.7 (0.8) 9.5 (0.6) 9.7 (0.5) 9.8 (0.5) 9.6 (0.5) 0.784 0.741
Prevotella spp. 7.9 (3.9) 7.9 (3.6) 7.5 (3.5) 7.3 (3.8) 7.7 (3.2) 8.1 (2.9) 0.882 0.725
Clostridia Cluster XIVa 9.8 (1.0) 9.6 (1.1) 9.6 (1.4) 9.9 (1.5) 10.1 (0.7) 10.1 (0.8) 0.784 0.661
Roseburia spp. 9.4 (0.7) 9.5 (0.7) 9.2 (0.7) 9.5 (0.5) 9.4 (0.5) 9.4 (0.6) 0.996 0.111
Cluster IV Ruminococcus 8.6 (1.0) 8.4 (1.6) 8.4 (1.3) 8.6 (1.6) 8.6 (0.9) 9.0 (1.2) 0.179 0.661
Lactobacillus spp. 6.7 (2.5) 6.7 (2.8) 6.2 (2.2) 6.2 (2.4) 6.5 (2.3) 6.7 (1.0) 0.256 0.711
Faecalibacterium prausnitzii 9.5 (0.7) 9.5 (1.1) 9.4 (0.7) 9.5 (0.8) 9.6 (0.6) 9.6 (0.7) 0.524 0.367
*Planned contrasts for change in biﬁdobacteria from baseline: Prunes vs control (P 0.057) and 80 g/d vs 120 g/d (P 0.121).
a Values are median (IQR) Bacteria in log10/g dry faeces measured at baseline and at week 4. Due to a technical issue with the qPCR assays for three subjects, data for 117
subjects were analysed for gut microbiota concentration.
b P values are the result of a KruskaleWallis test.
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signiﬁcant differences between groups in change from baseline
for any other bacteria measured, nor for absolute values of SCFA,
stool pH or stool water at the end of the intervention (data not
shown).
4. Discussion
This study has demonstrated that prunes resulted in a greater
increase in stool weight. However, there were no signiﬁcant dif-
ferences between groups in absolute stool weight under the ITT
analysis, despite signiﬁcant differences in the per protocol analysis,
which might be explained by the ITT analysis producing conser-
vative effect size estimates because of the use of ‘last observation
carried forward’ for missing data. The change in stool weight
equated to an increase of approximately 27.5 g/d per 100 g of
prunes (Fig. 2), an effect size that is consistent with a previous
study that demonstrated a 26 g/d increase in stool weight with
100 g/d prunes [22]. Based on these results, the hypothesis that
consumption of prunes at doses of 80 g/d or 120 g/d in addition to
the normal diet affects stool weight can be accepted.
We also found that prunes signiﬁcantly increased stool fre-
quency. This was expected because stool frequency correlates with
stool weight [30] and conﬁrms a previous study in constipation in
which 100 g/d prunes increased stool frequency by one BM per
week [31]. However, three previous studies in people without
constipation reported prunes had no effect on stool frequency
[22,23,32], although subjects in two of these studies had a baseline
frequency greater than one BM per day and stool frequency has
been reported to respond to dietary ﬁbre only when less than once
daily [33]. The mechanisms through which ﬁbre impacts on stool
weight and frequency are thought to include an increase in non-
digestible, non-fermentable bulk in the colon which has a greater
water-holding capacity, together with supporting bacterial meta-
bolism and bacterial numbers in the colon.
Fibre is thought to mediate its effect on stool output by
reducing WGTT, however, we did not ﬁnd any differences in
WGTT between the groups. This was unexpected because stool
weight has an inverse relationship with transit time [34] and
similar increases in ﬁbre intake to those in the current study (e.g.
9 g/d wheat ﬁbre) have decreased WGTT [35]. However, the effect
of ﬁbre on transit time may be inﬂuenced by ﬁbre type. Pectin,
one of the ﬁbre components of prunes, has little effect on WGTT
[36,37] but delays gastric emptying approximately twofold,
possibly due to its viscous, gel-forming properties [38]. Fibre hasbeen found to normalise transit time [30,39] with the greatest
reductions in those with slowest transit [4]. In the current study,
the mean baseline WGTT was within the normal range [40],
which may account for the lack of effect of prunes on this
outcome.
Although prunes were generally well tolerated, they caused a
small increased incidence of ﬂatulence. This is likely the result of
increased colonic fermentation of components in prunes such as
pectin and sorbitol, although there was no measurable change in
faecal SCFA or pH. Previously, 10 g of pure sorbitol induced gas and
bloating in healthy subjects [41]. Although statistically signiﬁcant
the effect size was relatively small, with the difference in incidence
of moderate/severe ﬂatulence being 1.3 days/week for the 120 g/
d group compared with control.
A difference in change in biﬁdobacteria was detected across
the groups, with þ0$3 log10 increase occurring in the 120 g/
d prune group. This is of interest because Biﬁdobacteria exert a
number of effects that may contribute towards host health [42].
Although the increase was small in logarithmic terms, this can
correspond to a substantial increase in absolute bacterial
numbers which may alter biological activity [43]. Moreover, the
increase in biﬁdobacteria observed is in the same order of
magnitude as that observed in some studies investigating the
prebiotic effects of inulin [44] and fructo-oligosaccharides [45].
The effect of prunes on the microbiota may be mediated by di-
etary ﬁbre (e.g. pectin), sorbitol or phenolic compounds [17,18,46]
but more research is required to conﬁrm this ﬁnding and to
establish which prune components are responsible for the in-
crease in biﬁdobacteria.
Dietary analysis revealed that subjects in both prune groups
consumed more energy than controls, despite no differences in
body weight during the study. This was due to a reduction in re-
ported energy intake from diet in all groups between baseline and
week 4, with prunes intakes (reported in separate compliance di-
aries) resulting in additional energy intake. It is possible that sub-
jects under-reported dietary intake, a problem widely
acknowledged in dietary assessment [47].
An increase in dietary ﬁbre consumption is the ﬁrst line treat-
ment for constipation [48], however, the effectiveness of food-
based dietary ﬁbre for treating constipation has been evaluated
by few trials [49] and a recent systematic review identiﬁed that the
quality of studies for ﬁbre supplementationwere either low or very
low [50]. In the present study, both prune groups experienced an
increase in stool weight and frequency, in line with a previous
study reporting that prunes were superior to psyllium in
E. Lever et al. / Clinical Nutrition 38 (2019) 165e173172constipation [31]. Another study reported that prunes/ﬂixweed
signiﬁcantly prevented constipation in pilgrims [51]. These results
suggest that prunes could be useful in the prevention or manage-
ment of constipation.
Epidemiological data suggest that stool weights >150 g/d and
ﬁbre intake of >24 g/d are associated with a reduced risk of colo-
rectal cancer [3]. At the end of the 120 g/d prune intervention,
mean stool weight was 123 g/d and ﬁbre intake was 21 g/d,
therefore at the group level not achieving these thresholds. The
effect of ﬁbre on stool weight varies according to ﬁbre type. Raw
wheat bran produces the greatest change in stool weight per gram
of non-starch polysaccharides (NSP) consumed (7.2 g), whereas
pectin appears to have the least effect (1.3 g per g NSP consumed)
[28]. In the present study, stool weight increased by 4.5 g/d per g of
prune NSP consumed, equivalent to 3.3 g/d per g of AOAC ﬁbre.
Therefore increasing ﬁbre intake with prunes will increase stool
weight, but doing so in conjunction with other ﬁbre-rich foods
could have a greater impact.
The strengths of the study include the randomised design, large
sample size and blinded data analysis. The ﬁndings of the per
protocol analyses were generally consistent with those from the
primary ITT analysis, although as expected, the ITT analysis pro-
duced conservative effect size estimates for stool weight.
Limitations included the difﬁculty in double blinding, because
prunes are easily identiﬁable and it was impossible to develop a
control identical in appearance but without any active components.
Therefore, blinding of subjects was attempted by using water as the
control and advertising the study as an investigation of the effect of
‘ﬁbre or ﬂuids’ on GI health, making the intervention and control
ambiguous. The success of subject blinding is unclear, and the
possibility of a placebo response cannot be ruled out. However,
subjective outcomes (e.g. GI symptoms) are particularly susceptible
to placebo responses, and for this reason numerous objective
measures were included (e.g. stool weight, WGTT). At baseline the
population had an average of 5 BMs per week and ﬁbre intake of
approximately 15 g/d (AOAC), both of which are below the average
for the general population, but which were speciﬁcally chosen to
reﬂect the intended consumer who may wish to increase ﬁbre
intakes.
In conclusion, this study has demonstrated that a four-week
intervention of 80 g/d or 120 g/d prunes resulted in greater in-
creases in stool weight. Prunes also increased stool frequency, were
relatively well tolerated in terms of GI symptoms and did not lead
to weight gain. Therefore, they have potential health beneﬁts in
populations where stool weights are low, including potentially
contributing to the prevention of constipation and other disorders
associated with low ﬁbre intake. Whether the effects are mediated
by dietary ﬁbre, sorbitol or phenolics, or the combination, remains
to be established.
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